This article is more than 5 years old. Information may no longer be current.

VIDEO: Dark adaptation a biomarker for AMD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS – Practitioners can use the AdaptDx by Maculogix to test a patient’s dark adaptation, which can be a biomarker for AMD, according to Bill McPhee, CEO of Maculogix.

“We wanted to launch a technology that will allow us to find the disease earlier, faster, smarter and easier, and it’s now available for all eye care practitioners,” he said here at the OIS meeting during SECO.